Greece
Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial
Nebulized dornase alfa endonuclease reduces inflammation, coagulopathy, and the length of hospitalization in individuals with severe COVID-19 pneumonia.
![Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial](https://europe.easybranches.com/uploads/news/2024/07/6581242.jpg)
Related
Share this page
Guest Posts by Easy Branches
Next
Yonhap News Agency
![Image](https://europe.easybranches.com/uploads/news/2024/07/6581241.jpg)